Public Company News

bp Extends its Partnership with Diebold Nixdorf to Support its Retail Sites and Payment Technology Globally

Strategic partnership includes extended, multi-year managed services agreement, and a unified, cloud-based platform to consolidate payment processes NORTH CANTON, Ohio, May 25, 2021 /PRNewswire/ -- Diebold Nixdorf (NYSE: DBD), a global leader in driving connected commerce for the retail and b...

2021-05-25 20:42 15301

Artmarket.com: real paintings by blue-chip artists remain the super-stars of the art market, says Artprice

PARIS, May 25, 2021 /PRNewswire/ -- The Art Market seemed to have forgotten its past and all of its reference points after the online sale of Beeple's ** Everydays (which sold for $69 million at the beginning of March). But the major New York spring sales showed that blue-chip artists (Picasso, Ba...

2021-05-25 20:00 13347

Boston Scientific Completes CE Mark for EXALT™ Model B Single-Use Bronchoscope

Company to begin limited market release in Europe in June MARLBOROUGH, Mass., May 25, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the EXALT™ Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures in the...

2021-05-25 18:50 3411

QAD Tomorrow Thought Stream Identifies Supplier Management Challenges and Provides Best Practices for Optimizing Supply Chains for Efficiency, Agility, and Resilience

JAKARTA, Indonesia, May 25, 2021 /PRNewswire/ -- QAD Inc. (Nasdaq: QADA ) (Nasdaq: QADB ), a leading provider of flexible, cloud-based enterprise software and services for global manufacturing ...

2021-05-25 16:29 14485

Sport & Outdoor Industry expert Markus Hefter joins Polygiene

STOCKHOLM, May 25, 2021 /PRNewswire/ -- Polygiene announces the appointment of the Sport and Outdoor Industry and ISPO veteranMarkus Hefter as Commercial Director for the EMEA region. After over 20 years of leading roles in the live communications & events industry he is now joining the team at P...

2021-05-25 15:57 2105

Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion

* SEEGENE POSTS KRW 193.9 BIL. IN OPERATING PROFIT, UP 388% ON-YEAR * OPERATING PROFIT RATIO AT 55%, DESPITE CONSTANT INVESTMENT IN R&D AND EMPLOYEES SEOUL, South Korea, May 25, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a molecular diagnostics company reported its financial results for th...

2021-05-25 15:33 12146

Nordic Choice Hotels Launches the Nordic Region's First 5G-connected Hotel in Collaboration with Tele2 and Speeron

STOCKHOLM, May 25, 2021 /PRNewswire/ -- In collaboration with Tele2 and IT partner Speeron, the Nordic region's first 5G-connected hotel is now being launched at Comfort Hotel Xpress inStockholm. With 5G, Nordic Choice will, in addition to fast connection in the rooms, be able to offer guests new...

2021-05-25 15:33 5844

LTI Launches Operational Technology Transformation Solution with ServiceNow

Designed for manufacturing industry, the solution improves visibility, security & service of Operational Technology assets MUMBAI, India, May 25, 2021 /PRNewswire/ --  Larsen & Toubro Infotech  (BSE: 540005), (NSE: LTI), a global technology consulting and digital so...

2021-05-25 14:47 4382

Positive Profit Alert: Expecting a Profit Attributable to Owners of 6.4-7.7x of FY2019/20, Reaching c. HK$70-85 million

HONG KONG, May 25, 2021 /PRNewswire/ -- A specialist in design, manufacturing and Internet of Things ("IoT") solutions in the electronics manufacturing services industry –Computime Group Limited ("Computime" or the "Company", together with its subsidiaries the "Group", stock code: 320.HK) is plea...

2021-05-25 11:11 4498

FIMER to Power Asia's First Automatic Frequency Control Initiative

* FIMER has partnered with Taiwan Stock Exchange (TSE)-listed smart energy conglomerate Tatung (Tatung:2371) to supply battery energy storage systems (BESS) for Taiwan Power Company (Taipower)'s automatic frequency control (AFC) initiative. * FIMER will supply its PVS980-58BC bidirectional ...

2021-05-25 09:00 2825

PayMyTuition Supports Strategic Expansion in China with Selection of Fiserv to Enable Local Payment Methods for Overseas Services

SHANGHAI, May 25, 2021 /PRNewswire/ -- PayMyTuition, a leading provider of technology-driven global payment processing solutions for tuition payments, is supporting a strategic expansion inChina with the selection of Fiserv to facilitate tuition payments for Chinese students attending colleges...

2021-05-25 08:30 5032

Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA

HANGZHOU and SHAOXING, China, May 25, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that following the consultation with China National Medical Products Administration (NMPA), the clinical trial application of ASC40 combined with bevacizumab to treat patients with re...

2021-05-25 08:30 3468

Innovent Announces First Patient Dosed in China in the Global Phase 3 Clinical Trial of Pemigatinib as the First-line Treatment of Unresectable or Metastatic Cholangiocarcinoma

SAN FRANCISCO and SUZHOU, China, May 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...

2021-05-25 08:00 11814

Antengene Appoints Kathryn Gregory as Vice President and Head of Corporate Business Development

SHANGHAI and HARTFORD, Conn., May 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and...

2021-05-25 08:00 4553

CLPS Incorporation Announces Strategic Cooperation with MCT, a Hong Kong Listed Company, to Develop a Next Generation Loan Trading Software

HONG KONG, May 24, 2021 /PRNewswire/ -- CLPS Incorporation (Nasdaq: CLPS) ("CLPS" or "the Company"), today announced a strategic cooperation with Minshang Creative Technology Holdings Limited ("MCT", 01632.HK) to jointly develop a next generation loan trading software and to explore global financ...

2021-05-24 20:30 6900

Biovaxys Strengthens Internal Expertise With Appointment Of Scientific Advisor For Ovarian Cancer Vaccine Clinical Program And Papilocare Marketing

VANCOUVER, British Columbia, May 24, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, US OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce thatCharles J. Dunton, MD, has joined BioVaxys as an Advisor to help provide additional scientific support for BVX-0918A,...

2021-05-24 20:00 7469

Ping An Supports Global Poverty Alleviation, Taking Successful China Handicraft Project to Cambodia

HONG KONG and SHANGHAI, May 24, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318) announced a new poverty alleviation program forCambodia at the International Forum on Poverty Governance and Development Towards Moder...

2021-05-24 19:34 15214

Akeso's Penpulimab Monoclonal Antibody Submitted BLA in the United States

HONG KONG, May 24, 2021 /PRNewswire/ -- On May 24, 2021, Akeso, Inc. (HKEx: 9926.HK) announced that Penpulimab (research and development code: AK105), an PD-1 monoclonal antibody drug co-developed by the Company with Sino Biopharmaceutical Limited (HKEx: 1177.HK), has submitted a Biologics Licens...

2021-05-24 18:17 3369

CanSinoBIO Receives European GMP Certification for its COVID-19 Vaccine Convidecia™

* A major step for introducing Convidecia™ to more countries and people in need for protection * Vaccine has been approved in China, Mexico, Pakistan, Hungary and Chile * Provides timely clinical protection for adults aged 18 and above, including those over 60 TIANJIN, China, May 24, 2021 /P...

2021-05-24 17:00 6489

Daewoong, first-in-class PRS-inhibitor for Idiopathic Pulmonary Fibrosis (IPF) shows promising result in early stage clinical test

* We confirmed the safety of 'DWN12088' and secured grounds for establishing treatment dosage * Confirming the potential as a treatment for IPF and planning to apply for Ph.2 within 2021 * 2nd ODD granted as treatment for systemic sclerosis from the US FDA SEOUL, South Korea, May 24, 2021 /...

2021-05-24 16:59 2014
1 ... 817818819820821822823 ... 890